• Embed Doc
  • Readcast
  • Collections
  • CommentGo Back
Download
Minnesota\u2019s
Bioscience Industry
A
F A C T
S H E E T
F O R
B U S I N E S S E S
Biotechnology advances use applications developed by the medical
technology industry, and Minnesota\u2019s medical technology industry
is recognized worldwide for being at the forefront of innovation.
Medical
Technology:
\ue001\ue000Minnesota\u2019s medical technology industries supply a diverse range of
products that include:
\ue002\ue000Cardiovascular technologies such as heart valves, pacemakers,
defibrillators and stents (Medtronic; St. Jude Medical; Boston
Scientific, Inc.).
\ue002\ue000Catheter technologies (Medtronic; St. Jude Medical; Boston
Scientific, Inc.; Smith\u2019s Medical).
\ue002\ue000Drug delivery systems (3M; Cima Labs, Inc.; Medtronic;
Smith\u2019s Medical).

\ue002\ue000Dialysis products(Minntech).
\ue002\ue000Impotence products (American Medical Systems).
\ue002\ue000Electrotherapy (Medtronic; St. Jude Medical; Compex

Technologies, Inc.; Empi Inc.).

\ue002\ue000Spinal implants (Sulzer Spine-Tech).
\ue002\ue000Warming products for hypothermia (Arizant, Inc.).
\ue002\ue000Hearing aids (Starkey Laboratories; Miracle Ear).
\ue002\ue000Eyewear lenses (BMC Industries; Soderberg Opthalmic Services).
\ue002\ue000Medical device contract manufacturing (ev3, Inc.; Lake Region

Manufacturing; Medsource Technologies; Surgical Technologies).
\ue002\ue000Drug-eluting coating process for medical devices(SurModics).
\ue002\ue000Drug-coated stents (Boston Scientific, Inc.; Medtronic).
0
10
20
30
40%
Minnesota
United States
PercentChan
ge
39.4%
4.2%
Top Medical Technology
Manufacturers Operating in Minnesota
Annual Sales*
Company
(millions)
Medtronic, Inc.
$11,292
3M \u2013 Health Care
4,373
Boston Scientific Scimed, Inc.
3,551
St. Jude Medical, Inc.
2,915
American Medical Systems, Inc.
263
\ue001\ue000Minnesota\u2019s medical technology industry employment:
\ue002\ue000Increased 43 percent between 1994 and 2004 to over 23,800
people.
\ue002\ue000Had a concentration of employment over three times the nation\u2019s.
\ue002\ue000Ranks second only to California in the medical device
industry.
\ue001\ue000A number of medical technology companies have appeared on the
prestigious Fast 500 list prepared by Deloitte and Touche.
\ue002\ue000MGI Pharma revenues grew more than 700 percent and Vital
Images revenues tripled between 2001 and 2005.
\ue001\ue000Synovis Life Technologies, ASV, andPossis Medical were among
Fortune magazine\u2019s 100 Fastest-Growing Companies for 2004.
\ue001\ue000Minnesota companies and research institutions have been first in
developing many important medical devices:

\ue002\ue000Implantable cardiac pacemaker.
\ue002\ue000Artificial heart valves.
\ue002\ue000Implantable drug transfusion pump.
\ue002\ue000Anesthesia monitor.
\ue002\ue000Blood pumps.
\ue002\ue000Artificial urinary sphincter.
\ue002\ue000In-the-ear hearing aid.
\ue002\ue000Wireless cardiac monitoring system.

\ue001\ue000Minnesota medical technology companies have been involved in
numerous mergers and acquisitions.
\ue002\ue000Medtronic, Inc. announced the acquisition of four companies

in 2002, including California-based MiniMed and Medical Research Group, Inc. (MRG). Medtronic made acquisitions totaling nearly $13.9 billion between 1996 and 2002.

\ue002\ue000Since 2002, ev3, Inc. has acquired Appriva Medical, Inc. of
California and Minnesota\u2019s Intra Therapeutics.
\ue002\ue000Medsource Technologies acquired Cycam, Inc. of
Pennsylvania, while American Medical Systems acquired
California-based CryoGen, Inc. in 2002.
Employment Growth in
Medical Technology Industries*, 1995-2005
* NAICS 334510, 334517 and 3391.
Source: U.S. Department of Labor, Bureau of Labor Statistics, Quarterly Census of
Employment and Wages (ES-202).
\ue001 There are 585 FDA approved medical device establishments
currently in Minnesota.
\ue001 About 2,500 medical device related patents were registered to
Minnesota companies between 2001 and 2005.
\ue001 According to the Milken Institute, Minnesota has the nation\u2019s
highest number of investigational medical devices and FDA pre-
market approvals of medical devices per 100,000 residents .
Outstanding
opportunities
for
collaboration
\ue002 Mayo Clinic: world\u2019s best known health care facility
also collaborates with health care and medical
technology companies.
\ue002 Industrial Partnership for Research in Interfacial
and Materials Engineering (IPRIME): Facilitates the

use of University of Minnesota equipment and staff
for its members, which include businesses such as
Medtronic, SurModics, and 3M (www.iprime.umn.edu).

\ue002The University of Minnesota\u2019s Biomedical
Engineering Institute combines engineering and
health sciences to create new medical devices.
* Sales for Minnesota headquarters or Minnesota-based operations
Source: Corporate Report Factbook 2007, Dun & Bradstreet , Reference USA, company annual reports.
Pharmaceuticals:
Minnesota\u2019s pharmaceutical industry is vibrant
and fast growing.
\ue001\ue000Minnesota is home to about 10,700 pharmacists and pharmacy
technicians, as well as 2,300 chemists and chemical technicians.
\ue001\ue000Twenty-nine Minnesota establishments have prescription and
over-the-counter drugs currently listed with the FDA.
\ue001\ue000Between 1997 and 2001, Minnesota companies registered more than
300 drug patents.
Top Pharmaceutical Manufacturers
Operating in MinnesotaAnnual Sales*
Company
(millions)
MGI Pharma, Inc.
$279
Solvay Pharmaceuticals, Inc.
150**
Hawkins Pharmaceutical Group
143
Upsher-Smith Laboratories
80**
Cima Labs, Inc.
76

* Sales for Minnesota headquarters or Minnesota-based operations
** Estimate.
Source: Corporate Report Factbook 2007, Dun & Bradstreet, Reference USA,

company annual reports.
0
10
20
30
40%
Minnesota
United States
PercentChan
ge
36.3%
19.7%
Employment Growth in the
Pharmaceuticals Industry*, 1995-2005
* NAICS 3254
Source: U.S. Department of Labor, Bureau of Labor Statistics, Quarterly Census of
Employment and Wages (ES-202).

Excellent
research
and
educational
institutions

Vanguard
in
Research

Educated
and
motivated
workforce:

\ue002 The University of Minnesota\u2019s College of Pharmacy
has programs in the Twin Cities and Duluth, and

confers degrees on more than100 students each year in its professional program, while about 375 chemistry degrees and almost 1,400 biological and life sciences degrees were awarded in Minnesota in 2000.

\ue002 Nanocopeia, Inc., a startup company utilizing research
developed by U of M professor David Pui and his
colleagues, creates nanotechnology devices for drug
formulation, gene therapy and tissue regeneration.
\ue002One of U.S. News and World Report\u2019s 10 leading
innovators for 2001, Dr. Catherine Verfaillie is a professor
with the Stem Cell Institute at the University of Minnesota.
\ue002 U of M researcher, Dr. Gunde Georg, is a leader
in the design, semi synthesis, total synthesis and
evaluation of biological active agents.
\ue002 Minnesota\u2019s labor force participation rate of 72.1
percent was second highest in the country in 2003.
\ue002Ninth highest percent of population holding
bachelors degrees among the states in 2003.
\ue002Second in the percentage of residents who are high
school graduates or higher in 2003.
\ue001\ue000Minnesota\u2019s pharmaceutical industry supplies a diverse range of
products that include:

\ue002\ue000Cardiology (Upsher-Smith, Solvay Pharmaceuticals)
\ue002\ue000Oncology-related pharmaceuticals (MGI Pharma)
\ue002\ue000Dermatology(Upsher-Smith)
\ue002\ue000Gastroenterology, mental health (Solvay Pharmaceuticals)
\ue002\ue000Immune system enhancing compounds(Biothera)
\ue002\ue000Women\u2019s health (Solvay Pharmaceuticals)
\ue002\ue000Orally disintegrating dosage forms and contract

pharmaceutical manufacturing (Cima Labs, Inc.)
\ue002\ue000Bioequivalent generic pharmaceuticals(Paddock
Laboratories, Upsher-Smith)
\ue002\ue000Animal health drugs (Intervet, Newport Laboratories)

Medicinal and Botanical,
and Other
Biological Product
Manufacturing 8%

In-Vitro Diagnostic Substance
Manufacturing 35%

Pharmaceutical
Preparation
Manufacturing 57%

Minnesota Employment in the
Pharmaceuticals Industry*, 2005
* NAICS 3254
Source: U.S Department of Labor, Bureau of Labor Statistics, Quarterly Census of
Employment and Wages (ES-202).
\ue001\ue000Pharmaceutical companies operating in Minnesota are among
the best in the nation.
\ue002\ue000Solvay Pharmaceuticals, listed among the top 50
pharmaceutical companies by Pharmaceutical Executive,
has a significant manufacturing presence in Baudette, MN.
Upsher-Smith Laboratories, Inc. has grown into one of the
world\u2019s top pharmaceutical companies with state-of-the-art
facilities headquartered near Minneapolis, MN.
\ue002\ue000CIMA LABS, Inc. appeared on the prestigious 2004 Fast
500 prepared by Deloitte and Touche with growth of more
than 460 percent over five years, and was listed as one of
Fortune magazine\u2019s 100 Fastest-Growing companies in 2003
\ue002\ue000Biothera engineers natural carbohydrates to enhance
immune health. The company has developed a compound
that triggers the body\u2019s immune system to kill tumor cells.
\ue002\ue0003M Health Care recently launched a new Medical
Diagnostic business that will offer new rapid diagnostic
tests.
\ue001\ue000Minnesota enjoys an excellent quality of life:
\ue002\ue000Minnesota has been rated among the top two \u201cMost Livable\u201d
states by Morgan Quitno Press for the past eight years.
\ue002\ue000Minnesota was first in the nation for children\u2019s well-being
according to the 2004 Kids Count Databook.
\ue002\ue000Home ownership rate was first in the country in 2003.
Minnesota companies shine in the diverse human health
microbiology field.
\ue001 About 1,600 biological and life sciences degrees were awarded in
Minnesota between 2003 and 2004.
\ue001Minnesota is home to about 1,300 biological scientists and
technicians, as well as more than 2,800 life scientists and other
science technicians.
\ue001 Firms in Minnesota are exploring new advances in microbiology:
\ue002\ue000R&D Systems-Techne Corp. manufactures purified cytokines

(proteins), antibodies, and assay kits as well as whole-blood
hematology controls and calibrators. The company has been
listed among the Top 25 Medical Technology Companies as of
2003 by The Business Journal.

\ue002\ue000Beckman Coulter Inc. manufactures in vitro immunodiagnostic
systems for allergies, infectious diseases, immunology,
hormones, and serum proteins.
\ue002\ue000Protein Design Labs, Inc. has antibodies in clinical development
for autoimmune and inflammatory conditions, asthma and cancer.
Human Health
Microbiology:
Top Human Health Microbiology
Companies in Minnesota
Annual Sales*
Company
(millions)
R&D Systems \u2013 Techne Corp.
$203
PDL BioPharma
90**
Medtox Scientific, Inc.
64
AppTec Laboratory Services
35**
Viromed Laboratories - LabCorp
10**
*Sales for Minnesota headquarters or Minnesota-based operations.
**Estimate.
Source: Corporate Report Factbook 2007, Dun & Bradstreet, Reference USA,
company annual reports.
Exceptional

Biological Research Facilities

\ue002 The University of Minnesota provides state-of-the-
art imaging and advanced genetic analysis facilities
to companies through the \u201cBiotech Mall\u201d known as
\u201cBiodale\u201d.
\ue002 Nearly $500 million has been invested in genomics
and biotechnology by the University of Minnesota
and the Mayo Clinic.
\ue002 The University of Minnesota has the Biotechnology

Institute, Developmental Biology Center, Biomedical
Engineering Institute, and the Biomedical Genomic
Center. The Mayo Clinic has the Genomics
Research Center.

\ue002University Enterprise Laboratory is a biotech
incubator launched in 2003 and has landed $24
million from investors.
\ue001\ue000Minnesota\u2019s human health microbiology industry supplies a diverse
range of products that include:
\ue002\ue000Contract R&D laboratories (ATG Laboratories, ViroMed,
Apptec Laboratory Services)

\ue002\ue000Cell culture products (ViroMed, Apptec Laboratory Services)
\ue002\ue000Immunoassay testing (Beckman Coulter)
\ue002\ue000Cytokine-related reagents (R&D Systems)
\ue002\ue000Hematology controls and calibrators (R&D Systems)
\ue002\ue000Immunoassay and conjugate stablilizers(SurModics)
\ue002\ue000cGMP manufacturing services (Apptec Laboratory Services)
\ue002\ue000Occupational health testing (Medtox Scientific Inc.)

\ue001\ue000Minnesota Partnership for Biotechnology and Medical Genomics:
Leverages the scientific leadership of the University of Minnesota

and the Mayo Clinic into a powerful research collaboration to position Minnesota as a world leader in biotechnology and medical genomics. (www.minnesotapartnership.info)

\ue001\ue000Mayo Clinic is using IBM\u2019s Blue Gene supercomputer to advance
work in molecular modeling for disease research.

Minnesota is well positioned with abundant
agricultural resources and top industrial
biotechnology firms.

Agricultural and
Industrial Biotechnology:
\ue001 Minnesota\u2019s Agricultural and Industrial Biotechnology industries
supply a diverse range of products that include:

\ue002\ue000Agricultural chemicals (Cargill Inc., Cenex Harvest States)
\ue002\ue000Specialty cleaning and sanitation preparations(Ecolab)
\ue002\ue000Sanitary products (H.B. Fuller)
\ue002\ue000Prepared feed and feed ingredients (Land O\u2019Lakes

Agricultural Services, Archer Daniels Midland, Cargill Inc.)
\ue002\ue000Crop services (Land O\u2019Lakes Agricultural Services,
Syngenta Seeds, Cenex Harvest States)
\ue002\ue000Biofuels (Cargill Dow LLC, Minnesota Corn
Producers \u2013 ADM)
\ue002\ue000Biopesticides(Syngenta)
\ue002\ue000Soybean processing (ADM, Cenex Harvest States, Ag
Processing Inc.)
\ue002\ue000Plant biopolymers/fibers (Cargill Dow)
\ue002\ue000Industrial lubricants (Cargill Inc.)
\ue001\ue000Cargill Dow LLC manufactures biodegradable packaging and

fibers using corn starch and a special fermentation process that
requires 20 to 50 percent less fossil resources. CEO Randy
Howard was named to the 2002 Scientific American 50, a list of
visionary contributors to science and technology.

\ue001\ue000Minnesota Corn Processors is the second largest domestic
producer of ethanol, and merged with Archer Daniels Midland in
2002.
\ue001 Land O\u2019Lakes provides farmers with:
\ue002\ue000Genetically engineered seeds through its seed company
Croplan Genetics that produce higher yields through crop
inputs and agricultural services.
\ue002\ue000Specialty corn products for animal feeds and consumer food
markets developed in conjunction with Novartis Seeds.
\ue001 Using a solvent process, Cenex Harvest States manufactures

soy products including edible refined oil, ink, flour, soy meal,
fatty acids and lecithin. In 2003, Cenex Harvest States opened its
second soybean crushing facility in Fairmont, Minnesota.

of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...
You must be to leave a comment.
Submit
Characters: ...